A Bayesian model for microarray datasets merging by Roubaud, Marie-Christine & Torrésani, Bruno
ar
X
iv
:1
51
0.
07
85
0v
1 
 [s
tat
.M
E]
  2
7 O
ct 
20
15
A Bayesian model for microarray datasets merging
Marie-Christine Roubaud and Bruno Torre´sani∗
Aix-Marseille Universite´, CNRS, Centrale Marseille, LATP, UMR 7353, 13453 Marseille, France
April 2012
The aggregation of microarray datasets originating from different studies is still a difficult
open problem. Currently, best results are generally obtained by the so-called meta-analysis
approach, which aggregates results from individual datasets, instead of analyzing aggre-
gated datasets. In order to tackle such aggregation problems, it is necessary to correct
for interstudy variability prior to aggregation. The goal of this paper is to present a new
approach for microarray datasets merging, based upon explicit modeling of interstudy vari-
ability and gene variability.
We develop and demonstrate a new algorithm for microarray datasets merging. The
underlying model assumes normally distributed intrinsic gene expressions, distorted by
a study-dependent nonlinear transformation, and study dependent (normally distributed)
observation noise. The algorithm addresses both parameter estimation (the parameters
being gene expression means and variances, observation noise variances and the nonlinear
transformations) and data adjustment, and yields as a result adjusted datasets suitable for
aggregation.
The method is validated on two case studies. The first one concerns E. Coli expression
data, artificially distorted by given nonlinear transformations and additive observation
noise. The proposed method is able to correct for the distortion, and yields adjusted
datasets from which the relevant biological effects can be recovered, as shown by a standard
differential analysis. The second case study concerns the aggregation of two real prostate
cancer datasets. After adjustment using the proposed algorithm, a differential analysis
performed on adjusted datasets yields a larger number of differentially expressed genes
(between control and tumor data).
The proposed method has been implemented using the statistical software R 1, and
Bioconductor packages 2. The source code (valid for merging two datasets), as well as
the datasets used for the validation, and some complementary results, are made available
on the web site
www.latp.univ-mrs.fr/∼mcroubau/MicroarrayMerging
1 Introduction
Microarray technology provides high throughput measurements of messenger RNA levels of thousands
of genes in tissue samples. Since its introduction almost twenty years ago, it has found applications
in many aspects of molecular genetics and functional genomics, from the discovery of basic biological
mechanisms to the classification of diseases into subgroups and the prediction of disease outcome.
1www.r-project.org, the R Project for Statistical Computing.
2www.bioconductor.org, Bioconductor, opensource software for bioinformatics.
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However, although important progress has been made, that has turned lab experiments into indus-
trially standardized protocols, the technology is still facing significant reproducibility problems (see
e.g. the introduction of [5] for a more detailed account). Therefore, comparing results from different
studies is generally difficult, and extreme care is needed if one wishes to merge different datasets into
a single one to improve reliability and generalizability of the results.
Several microarray study aggregation techniques have been proposed. Among them, two approaches
have received significant attention. The first one (see for example [4]) proposes to replace numerical
expression data with ranked data, in order to correct for study-dependent normalization effects. This
implicitely assumes that the ranks are essentially respected in the considered datasets; unfortunately,
such an assumption fails to be true in many situations, for example when a large number of weakly
expressed genes are present, the fluctuations of which induce large deviations in ranks. The second
classical approach, termed Meta-Analysis, aggregates the results of statistical analyzes from the differ-
ent datasets rather than aggregating the datasets themselves (see for example [1] for a review). It has
been argued by various authors (see for example [1, 2]) that such meta analysis approaches generally
outperform classical statistical analysis directly performed on aggregated datasets.
We propose in this paper a new approach for pre-processing gene expression datasets prior to ag-
gregation, as an alternative to meta-analysis based techniques. The idea is to start with an explicit
model for gene expression data, and an explicit model for the distortions induced by the different
experiments to be merged. In a Bayesian framework, those two models are used as priors. Assuming
normally distributed additive observation noises leads to a closed form expression for the posterior
probability.
This model is simple enough to yield a fairly standard estimation algorithm, exploiting elementary
linearization and optimization techniques. The latter yields estimates for the model parameters, to-
gether with adjusted gene expression values in which both the non-linear distortions and the variances
inhomogenities have been corrected, therefore suitable for aggregation and further statistical analysis.
The model and the algorithm are validated in both synthetic datasets (i.e. real datasets with an
artificial distortion and additional noise), for which the method is shown to be able to correct for the
distortion and noise (to some extent). We then apply the approach to real prostate cancer expression
datasets, for which two original datasets are aggregated after correction.
Preliminary results of this work have been given in conference proceedings [8].
2 Approach
The approach we develop here is based upon an explicit modeling of the gene expressions, and of the
distortion introduced by the several studies. For the sake of simplicity we limit ourselves to a simple
model for logarithms of gene expressions, assuming independent normally distributed values (with
unknown means and variances). We also assume that each study gives rise to a non-linear distortion
(called an observation function) of gene expressions, and an additive zero-mean Gaussian white noise,
of unknown variance. Our approach mainly relies on two steps. First, estimate the parameters of the
model (including the nonlinear observation functions), then estimate adjusted gene expression values,
that can be aggregated into a single dataset.
More precisely, we rely on the following model for logarithms of measured gene expression data.
Assume we are given several datasets k = 1, . . . K, involving g = 1, . . . Ng genes (if necessary, after
restriction to a suitable subset of common available genes). For each dataset k, several arrays (here-
after termed conditions c = 1, . . . Nkc are available. We denote by y
k
gc the logarithms of measured
gene expression levels, which we shall call throughout this paper the observed gene expressions. The
ingredients of the model are the following:
• The intrinsic gene expression values x = {xkgc} are assumed to be independent realizations of
i.i.d. normally distributed random variables Xg ∼ N (µg, σ
2
g) (whose distributions do not depend
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on the study k). We write
xkgc = µg + δ
k
gc .
• The observed gene expression values y = {ykgc} are obtained by a study-dependent nonlinear
transformation fk of the intrinsic expression values, with additive Gaussian noise, Y
k
g = fk(Xg)+
Uk, with Uk ∼ N (0, τ2k ). Componentwise, the observations therefore read
ykgc = fk(x
k
gc) + u
k
gc .
• The observation functions : f = {fk, k = 1, . . . K} are assumed to be monotonic, smooth
functions (
∫
|f ′′k (x)|
2 dx <∞), and are given a spline-type prior distribution
p(fk) ∼ exp
{
−λk
∫
∞
−∞
|f ′′k (x)|
2dx
}
.
Conditionally to the observation functions fk and the intrinsic gene expressions x
k
gc, the observed gene
expressions ykgc are therefore independent and normally distributed, with means fk(x
k
gc) and variances
τ2k . Applying the Bayes rule, it is easily seen that the log posterior probability distribution is (up to
an additive constant) equal to the sum of three components
L (x,f |y) = L (1) + L (2) + L (3) , with

L (1) =
∑
k,g
L
(1);k
g =−
∑
k,g
1
2τ2k
∑
c
[ykgc − fk(x
k
gc)]
2
L (2) =
∑
k,g
L
(2);k
g =−
∑
g
1
2σ2g
∑
k,c
[xkgc − µg]
2
L (3) =
∑
k
L
(3);k =−
∑
k
λk
∫
∞
−∞
|f ′′k (x)|
2 dx
(1)
The approach we develop here aims at maximizing numerically the above log-posterior probability,
estimating the gene average expressions µg and variances σ
2
g , the observation noise variances τ
2
k and
the observation functions fk, and solve the regression problem for estimating intrinsic gene expression
values xkgc.
3 Methods
We describe in this section the estimation method used in our approach, together with the corre-
sponding algorithm. The first step of the algorithm is the estimation of the model parameters: means,
variances and observation function. The chosen approach is an iterative one, each parameter is esti-
mated at the time. After the estimation, adjusted gene expression datasets are available, that can be
aggregated and analyzed.
3.1 Estimation
3.1.1 Observation functions estimation
Suppose firstly that the intrinsic gene expression values xkgc are fixed. Then the observation function
estimation problem reduces to the minimization with respect to f = {fk ∈ H
2(R), k = 1, . . . K} of the
quantity
Γ[f ] =
∑
k
[(∑
g
L
(1);k
g
)
+L (3);k
]
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and decouples further into the following K independent optimization problems: for k = 1, . . . K, solve
fk = argmin
f
{
1
τ2k
∑
g
[
ykgc − f(x
k
gc)
]2
+ λk
∫
|f ′′(x)|2 dx
}
.
The latter are actually smoothing spline regression problems (see e.g. [11] for a detailed account),
for which efficient algorithms are available and implemented in standard software packages. It is worth
noticing that spline functions being piecewise polynomials, once the spline has been estimated, its
derivative is readily available.
Remark 1 These estimations are performed on a set of genes with small variance across samples in
each experiment, termed below invariant gene set. This gene set must also be representative of the
range of values of the average gene expressions. Practically, the invariant gene set is determined as
follows:
• Split the range of values of the observed gene expressions into intervals.
• Within each interval, select a given percentage of genes with smallest variance.
3.1.2 Mean and variances estimation
The average gene expressions µg are re-estimated at each step of the algorithm as weighted sample
averages of the estimated gene expressions: at iteration t,
µg(t) =
1
KNc
∑
k,c
xkgc(t) ,
where Nc =
∑
k N
k
c is the total number of arrays.
The variance component estimation is a difficult task here, as many gene variances σ2g are to be
estimated. The I-MINQUE (or REML) approach (see e.g. [6]) is a natural choice, which is unfortunately
not suitable here as it produces negative estimates for the gene variances. To estimate the latter, we
choose sample estimates from the initialization (i.e. pre-adjusted expression data, see Section 3.1.4
below). To estimate the observation noise variances τ2k , we resort to the I-MINQUE approach, applied
to the invariant gene set (defined in Remark 1).
Remark 2 Our simulations (see the E.Coli example below) show that when the observation noise is
large, the corresponding variances τ2k can be underestimated by our procedure, which in turn results in
an overestimation of the gene variances. To overcome this problem, a possible solution is to regularize
the gene estimates by adding a positive constant λ2 to the estimated noise variances: modified estimates
of the form
τˆ2k = τ
2
k + λ
2
are considered. In practical situations, since the observation noise is unknown, the regularization
parameter λ can be used as a tuning parameter.
3.1.3 Adjusted gene expression values estimation
Suppose now that the observation functions fk are known, the minimization of the log posterior
probability in (1) leads to the optimization of
Γ′(x) =
∑
k,g
[
L
(1);k
g + L
(2);k
g
]
,
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which splits into a sum of Ng decoupled terms: the estimation of the intrinsic gene expression values
xkgc reduces to minimizing for each g = 1, . . . Ng the quantity
Φg(xg) =
∑
k,c
{
1
2τ2k
[
ykgc−fk(x
k
gc)
]2
+
1
2σ2g
[
xkgc−µg
]2}
,
where xg = {x
k
gc, k = 1, . . . K, c = 1, . . . N
k
c }.
Due to the non-linearity of the observation functions fk, no closed-form expression exist for the
solution, and we resort to an iterative numerical algorithm. We assume that the mean µg and variances
σ2g and τ
2
k are known, as well as the observation functions fk. At iteration t, assume that the previous
estimate xkgc(t−1) of the gene expression values is available. A linearization of the observation functions
fk in the neighborhood of x
k
gc(t− 1) yields the first order approximation x
k
gc(t) = x
k
gc(t− 1) + ǫ
k
gc, and
fk(x
k
gc(t)) ≈ fk(x
k
gc(t− 1)) + ǫ
k
gcf
′
k(x
k
gc(t− 1)) ,
from which we deduce
Φg(xg(t)) ≈
∑
k,c
{
1
2τ2k
[
ǫkgcf
′
k(x
k
gc(t−1))− (y
k
gc− fk(x
k
gc(t− 1)))
]2
+
1
2σ2g
[
ǫkgc − (µg − x
k
gc(t− 1))
]2}
The update xkgc(t) can therefore be obtained by optimizing with respect to ǫ
k
gc the above expression,
which yields
akgcǫ
k
gc =
f ′k(x
k
gc(t−1))
τ2k
(
ykgc−fk(x
k
gc(t−1))
)
+
1
σ2g
(
µg−x
k
gc(t−1)
)
,
where we have set akgc = [σ
2
gf
′
k(x
k
gc(t− 1))
2 + τ2k ]/σ
2
gτ
2
k .
Set now
αkgc =
1
akgcσ
2
g
=
1
1 + f ′k(x
k
gc(t− 1))
2σ2g/τ
2
k
,
Then 0 ≤ αkgc ≤ 1, the bounds being attained in the extreme cases (no noise, or constant fk). This
yields the update rule xkgc(t) = x
k
gc(t− 1) + ǫ
k
gc, i.e.
xkgc(t) = α
k
gcµg + (1− α
k
gc)
[
xkgc(t− 1) +
1
f ′k(x
k
gc(t− 1))
(
ykgc−fk(x
k
gc(t− 1))
) ]
.
i.e. a weighted average of the mean µg and the contribution of observations.
Remark 3 This is similar to empirical Bayes type update rules, the difference being that the weights
depend upon the observations, due to the nonlinearity of observation functions.
The balance between the contributions of the mean and the observations is controlled by the signal
to noise ratio (SNR) σ2g/τ
2
k . The larger the SNR, the smaller the α parameter and the larger the
contribution of the observations: adjusted values are closer to the observed ones. Conversely, for small
SNR values, adjusted gene expressions are closer to the means µg.
Remark 4 It may be shown that this update rule is actually equivalent to a variable step gradient
descent method:
xkgc(t) = x
k
gc(t− 1) + ǫ
k
gc(t− 1)∇xkgcΦ(x(t− 1)) ,
where the stepsize depends on the gene g, the condition c, the study k and the iteration index
ǫkgc(t− 1) = σ
2
gα
k
gc(t− 1) .
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3.1.4 Initialization.
The estimation procedures described above are used within an iterative algorithm. The latter needs
either initial values for the intrinsic gene expressions, or the observation functions, since only data y
is available.
We use an estimate for the reciprocal of the observation functions (the so-called rectification func-
tions) provided by the approach described in [7]. The estimation of rectification function is formulated
in [7] as another smoothing spline problem: optimize, with respect to the mean gene expressions µg
and the rectification functions ϕk the quantity
K∑
k=1
Ng∑
g=1
1
Nkc
Nkc∑
c=1
[
ϕk(x
k
gc)− µg
]2
+
K∑
k=1
λk
∫
|ϕ′′k(x)|
2 dx .
The problem is solved by an iterative algorithm, in the same spirit as the approach described here.
Besides the fact that the approach of [7] estimates rectification functions instead of observation func-
tions, the main difference with the current approach is that the latter models observation noise, which
is not the case of the former. The approach developed in the present work is more complex, but is
able to correct for study-dependent observation noise.
3.2 Algorithm
The proposed approach can be summarized as follows:
• Initialization: Start from a first estimate xkgc(0) for the intrinsic expression values, provided
by rectification function estimates (see section 3.1.4). Estimate the gene average expressions µg
and variances σ2g as in section 3.1.2, and the observation functions as in section 3.1.1.
• Iteration t: estimates xkgc(t− 1) are available.
∗ Re-estimate the gene expressions xkgc(t) as in 3.1.3.
∗ Update the mean gene expressions µg(t) as in 3.1.2.
The output of the algorithm consists in estimates xˆ = {xˆkgc} for the expression datasets x = {x
k
gc}, to
be exploited for further analyses, together with estimates for the means µg, variances σ
2
g and τ
2
k , and
the observation functions fk.
The algorithm was implemented using the R statistical environment, from which we used the smooth-
ing spline function smooth.spline. Bioinformatics related functions from the Bioconductor package
were also used.
3.3 Validation: differential analysis
Even though differential analysis is not the only application we have in mind, it provides a convenient
setup for validating the proposed approach. In the numerical results we discuss below, differentially
expressed genes were searched for in original (distorted) datasets and adjusted datasets, using t-test
with FDR correction for multiple testing. We used functionalities from the Bioconductor package,
namely the MTP function from the multtest package.
4 Results and discussion
The proposed approach has been tested and validated on several problems, of increasing complexity.
We first verified that the algorithm performs well on articifial data, i.e. random data simulated
according to the above model. The results are quite satisfactory, but since there’s not much to discuss
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Figure 1: Artificially distorted E.Coli dataset: observed data vs adjusted data, and estimated obser-
vation functions.
about such simulations we refrain from reporting on them here, and prefer to focus on results closer
to practical situations. We report below on two different validations of the approach. The first one
concerns semi-artificial data, namely real data, with clear biological outcome, which are artificially
distorted according to the distortion model above. We show that in such a situation, the proposed
approach allows one to almost completely correct for the effect of the distortion, and recover the
biological meaning of the data. The second validation is performed on two real human gene expression
datasets, focusing on prostate cancer.
4.1 Real data with artificial distortions
A test was performed using artificial observation functions, applied to real data. Namely, we chose
a dataset with well understood biological outcome, splitted it into two well balanced subsets denoted
by E1o and E2o (“o” stands for “original”, see below for details) and applied to the two subsets two
different observation functions, before adding Gaussian observation noise (yielding distorted subsets
E1d andE2d. After adjustment, datasets denoted by E1a andE2a were obtained, that were aggregated.
The goal was to study the impact of the deformation induced by the observation functions and the
noise (which were chosen so as to hide the biological effects), and the ability of the algorithm to perform
a sensible correction.
E. Coli expression data from [3] were used. The data include expressions of 7295 genes under two
different situations (20 aerobic and 22 anaerobic). They exhibit a clear variability between the two
biological situations, and are thus particularly interesting since they provide a good test of the ability
of our approach to recover such a variability after distortion and correction.
Two subsets were created, both involving randomly chosen 10 aerobic and 11 anaerobic conditions.
Non-linear transformations f1 and f2 were applied to the two so-created subsets (after standardization),
and observation noise with variances τ21 and τ
2
2 was added. We report here on the particular case
f1(x) = x
0.7 and f2(x) = x
1.4 ,
with various choices of the observation noise variances, similar results were obtained with different
choices of non-linearities. The values for the noise variances were chosen as a function of the standard
deviations of the distorted datasets, following the rules
τ1 = α std(f1(x1))/10 , and τ2 = 3α std(f2(x2))/10 ,
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Figure 2: Projections on the first principal plane. Top: original data (left) and distorted data (right).
Bottom: rectified data: initialization (left) and processed data (right). O: aerobic; N: anaer-
obic. Gray: dataset 1; black: dataset 2
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τ21 τˆ
2
1 τ
2
2 τˆ
2
2 〈σˆ
2
g〉
S1 2.5 10−3 3 10−3 2.25 10−2 2.1 10−2 1.6 10−2
S2 4.9 10−3 5 10−3 4.41 10−2 4 10−2 1.9 10−2
S3 1 10−2 7 10−3 9 10−2 7.1 10−2 2.6 10−2
S4 1.96 10−2 1.3 10−2 1.76 10−1 1.31 10−1 3.8 10−2
Table 1: Observation noise and average gene variance for the four simulated datasets and their estimation.
O D A E1o∩E2o E1d∩E2d E1a∩E2a
S1+ 258 121 (129) 162 (173) 5 1 1
S1- 328 139 (141) 187 (188) 31 9 10
S2+ 275 107 (112) 123 (129) 5 2 2
S2- 312 124 (129) 148 (155) 31 3 4
S3+ 238 71 (74) 88 (93) 5 1 1
S3- 305 105 (109) 113 (116) 30 3 4
S4+ 253 58 (60) 65 (68) 7 1 1
S4- 300 72 (73) 80 (81) 32 1 1
Table 2: Differential analysis on artificially distorted E.Coli dataset. The first column indicates the simulation
index (see Table 1 for the corresponding observation noise variances), the sign indicates over or under
expression in aerobic conditions. Column 2: numbers of differentially expressed genes in the original
dataset. Columns 3 to 7: numbers of differentially expressed genes in distorted (D) and adjusted (A)
datasets, and in the intersections E1o∩E2o, E1d∩E2d and E1a∩E2a that are present in the original
dataset (the numbers between parentheses indicate the total numbers of differential genes).
with various values of the tuning parameter α. Actual variance values, together with the corresponding
estimated values, are displayed in Table 1, together with the estimated average gene variance, denoted
by 〈σ2g〉. As can be seen, the estimates are fairly good, except for the last situation, which corresponds
to the value α = 20, presumably too large for our procedure (results continue to degrade for higher
values of α, which probably originates from the degradation of the gene variance estimates).
To illustrate graphically the effect of the adjustment, we display in Fig. 2 the first factorial plane
obtained by (normalized) principal component analysis with original data, distorted data, pre-adjusted
data (using the method of [7], used here as initialization, see Section 3.1.4), and adjusted data. The
projection of the output data xˆkgc onto the first factorial plane turns out to reproduce fairly accurately
the projection of the original data xkgc (before distortion). The processing has therefore permitted to
recover the biological features as the first source of variability. This is confirmed by visual inspection
of the projections on other factorial planes (not shown here).
A more quantitative validation can be obtained through differential analysis. We searched for genes
differentially expressed between aerobic and anaerobic conditions, on initial data, distorted data and
adjusted data, for various values of observation noise. For the sake of comparison with meta-analysis
based approaches, we also performed differential analysis on the two subsets E1 and E2 (in original,
distorted and adjusted situations) and computed the intersection of the two estimated gene subsets in
each situation. The goal of the comparison is to asses the ability of each approach to recover original
differentially expressed genes.
9
The results are displayed in Table 2, which gives the numbers of differentially expressed genes on
the original dataset (first column), and the number of original differential genes that are recovered on
the distorted dataset (second column) and the adjusted dataset (third column); total differential gene
numbers are given between parenthesis.
A first conclusion is that the distortion significantly degrades the differential analysis, the degra-
dation being obviously bigger when the observation noise is higher. The processing improves the
situation, which is reflected by an average increase of the number of the recovered original differential
genes ranging between 11% and 20% (depending on the noise level).
For the sake of comparison, we also display in the last three columns numbers of differential genes
obtained by intersecting the results of individual differential analysis on the two sub-datasets, in the
three considered situations. It is worth noticing that the loss of differential genes is in this case really
huge, which is for us a strong motivation for aggregating datasets rather than intersecting differential
analysis results.
4.2 Real data
The proposed approach was also tested on the two publicly available datasets of prostate cancer
expression data reported in [9] and [10]. Both datasets originate from Affymetrix HG-U95av2 arrays.
We started from raw expression data, and normalized them separately using the standard RMA
normalization procedure from the Bioconductor package. After normalization, the dataset of [9] ap-
peared to exhibit much larger variability than the [10] dataset. We thus performed the following
pre-processing: we extracted a subset of arrays whose correlations to the median array exceed 90%,
and reduction to common genes). After pre-processing, the two-datasets consist in respectively 61 (32
tumor and 29 normal) and 86 (37 tumor and 49 normal) conditions, with 12625 genes, from which we
extracted balanced sub-datasets (29 tumor and 29 normal for each)
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Figure 3: Estimated observation functions for the prostate datasets: Singh (left) and Stuart (right)
datasets
The proposed algorithm was run on these two datasets. The result of the processing is shown in
Fig. 3 (estimates for the observation functions) and in Fig. 4 (estimated variances, for the observed
and adjusted data). We first notice that the estimated observation functions are in this case fairly
regular, no large distortion has been found. It can be seen on Fig. 3 that the Singh data (termed E1)
have been shrunk more importantly than the Stuart data (E2). This can be interpreted in terms of
the observation noise. Indeed, the observation noise was found to be significantly larger in the Singh
10
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Figure 4: Prostate datasets: estimated gene variances in the original dataset (left) and the adjusted
dataset (right), in logarithmic scales
dataset than in the Stuart dataset: τˆ21 ≈ 2.6 10
−2 and τˆ22 ≈ 1.6 10
−2. Nevertheless, both values are
larger than the estimated average gene variance 〈σˆ2〉 ≈ 4.2 10−3. According to Remark 3, we are here
in a situation where the contribution of the average to the adjusted gene expression values tends to be
larger than the contribution of the observations.
Finally, it is clear from Fig. 4 that the proposed approach has done quite a good job for adjusting
the gene variances: variances in adjusted Singh and Stuart datasets are coherent. The interstudy
variability has therefore been considerably reduced.
As in the previous case study, to assess more quantitatively the performances of the proposed
approach, differential analysis was performed on the real dataset, and the adjusted dataset. After
filtering out the 30% least variable genes, we used t-test based decision rule, with FDR correction for
multiple testing (α = 5%, 5000 bootstrap samples). Differentially expressed genes were seeked for the
real dataset and the processed dataset, as well as the individual subsets E1 (Singh) and E2 (Stuart),
and the corresponding adjusted subsets E1a and E2a. The results are summarized in Table 3.
O A O∩A O\ A A\ O E1∩E2 E1a∩E2a
+ 73 88 66 7 22 4 5
- 232 245 217 15 28 1 1
Table 3: Differential analysis on the Prostate dataset: numbers of differentially expressed genes. First column:
aggregation of the two original datasets. Second column: aggregation of the two adjusted datasets.
Columns from 3 to 5: intersection and differences between original and adjusted. Columns 6 and 7:
intersections of original subdatasets and adjusted subdatasets respectively.
As before, a striking first result is the fact that the intersection of the differential genes found from
E1 and E2 individually is extremely small, as well as the the intersection of the differential genes found
from E1a and E2a individually. Quite a large number of differential genes appear to be lost by this
procedure. Besides, as was also seen in the above E. Coli simulation study, the adjusted datasets yield
a larger number of differential genes than the original datasets. A closer examination of the results of
the differential analysis leads to the following conclusions:
• The adjusted dataset features, after concatenation, a larger number of positively and negatively
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Figure 5: P-values of differential genes for the original and the adjusted datasets: Positively differential
genes in the original (O+) and adjusted (A+) datasets, and negativeley differential genes in
the original (O-) and adjusted (A-) datasets
differential genes. Even if one focuses on differential genes with small p-values (say, less than 1%),
the adjusted dataset yields a significant number of “new” genes, including for example MAP-
KAPK3, POLR2H, BDH1, PYCR1, PDIA4, SLC25A6, ZMPSTE21, ENTPD6 for the positively
differential genes (i.e. overexpressed in tumors), and ADD1, VAT1, PPP2CB, RBPMS, FSCN1,
ARHGEF4, GRK5, FEZ1, HTRA1, RBMS1, CETN2 and OSR2 for the negatively differential
genes.
A precise analysis of the role of these genes in prostate cancer goes far beyond the scope of the
present work. Let us simply notice that most of these genes have already been reported in the
prostate cancer literature. This makes them potentially interesting.
• Globally, the p-values of differential genes are smaller in the adjusted dataset than in the original
dataset. This appears clearly in Fig. 5 where they are displayed in boxplot forms.
• Conversely, less genes were found differential in the original dataset only; in addition, the cor-
responding p-values are generally close to the critical value chosen in this study (5%). A closer
examination shows that their variance in the adjusted dataset is smaller than in the original
one. According to Remark 3, this presumably originates from a low signal to noise ratio σ2g/τ
2
k ,
or a large value of the observation function derivative f ′(µg) (in the present approach, these
quantities govern the parameter αkgc which controls the variance in the adjusted dataset).
5 Conclusion
We have proposed in this paper a new approach for aggregating gene expression datasets originating
from different studies. The rationale of the method is to adjust the datasets prior to merging, using
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a Bayesian modeling. The model we develop is specifically adapted to microarray data, and assumes
that the inter-study variability originates from non linear distortions, combined with study dependent
observation noise. The inter-study variability model is combined with a Gaussian model for the gene
expression values (after logarithmic transformation) in a Bayesian framework.
Our results on artificial and real data show that the method is sound, and capable of correcting for
study-dependent distortion and observation noise. For the sake of simplicity, we focused on the case
of two datasets to be merged, however the model is versatile enough to accomodate arbitrary numbers
of datasets. The results on real data discussed here are quite encouraging, however the approach will
have to be tested further on a larger scale to be validated more thoroughly.
Several aspects are to be investigated further. Among them, the problem of variance components
estimation is an important one, as the estimated gene variances have a key impact on the quality of
the results. For the sake of simplicity we have limited ourselves here to a simple procedure, involving
sample estimates of gene variances from pre-adjusted data. More sophisticated approaches will have
to be investigated.
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